The treatment of parkinsonism with levodopa.
D000368:Aged; D000856:Anorexia Nervosa / Q000139:chemically induced; D001480:Basal Ganglia Diseases / Q000139:chemically induced; D003863:Depression / Q000139:chemically induced; D004295:Dihydroxyphenylalanine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D005116:Extrapyramidal Tracts / Q000187:drug effects; D005152:Facial Muscles; D005260:Female; D006801:Humans; D007022:Hypotension / Q000139:chemically induced; D008046:Lip; D009069:Movement Disorders / Q000139:chemically induced; D010300:Parkinson Disease / Q000188:drug therapy*; D011379:Prognosis; D013997:Time Factors; D014059:Tongue; D014592:Uterine Hemorrhage / Q000139:chemically induced
D004295:Dihydroxyphenylalanine